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Vertebrate DNA is subjected to epigenetic base
modifications that have been thought to be limited to
methylated and other modified forms of cytidine. A
recent study shows that methylation of adenine to
form N6-methyladenine is a rare but readily detectable
modification that can be mapped to distinct genomic
sites in vertebrates.cleavage by restriction endonucleases, while enablingBackground
Epigenetic modifications expand the information content
of DNA and have long been known to exist in the ge-
nomes of diverse organisms. The most well-studied base
modification in vertebrates and higher eukaryotes is
methylation of the C-5 position of cytosine residues,
which forms the 5-methylcytidine (m5C) nucleotide.
m5C is often detected at CpG dinucleotides where it in-
fluences transcription by recruiting repressive m5C-bind-
ing proteins or preventing the binding of transcription
factors [1]. Importantly, cytidine methylation is a revers-
ible modification, and both methylation and demethyla-
tion pathways contribute to dynamic regulation of m5C
signatures which control both developmentally regulated
and activity-dependent gene expression programs [1].
Demethylation of m5C residues has been shown to in-
volve the formation of oxidized intermediates, such as
5-formylcytidine and 5-hydroxymethylcytidine, which
also contribute to gene expression control. Thus, the
cytidine nucleotide has long been considered to be the
major site of DNA base modifications contributing to
transcriptional regulation in vertebrates and other
eukaryotes.* Correspondence: srj2003@med.cornell.edu
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contain additional DNA base modifications. These
include C-4-methylated cytosine (4mC), as well as meth-
ylated adenine (N6-methyladenine, or 6 mA). The meth-
ylated base, 6 mA, or the corresponding nucleotide
N6-methyldeoxyadenosine (m6dA), is an important
component of the restriction/modification system used to
defend against bacteriophage invasion. This system uses
the methylation of host cell DNA to protect it against
invading, unmethylated genomic material to be cleaved. In
addition to its role in host defense pathways, m6dA is also
an important regulator of DNA replication, repair, and
transcriptional control in prokaryotes [2].A new addition to the vertebrate epigenome
Although m6dA is a readily detectable feature of bacter-
ial genomes, it has been more difficult to definitively es-
tablish its presence in the genomes of higher organisms.
This contrasts with mRNA, where mapping of the ribo-
nucleotide equivalent of m6dA, N6-methyladenosine
(m6A), has identified m6A sites in thousands of mam-
malian mRNAs [3]. Studies aimed at detecting m6dA in
the DNA of higher organisms [4] have failed to uncover
evidence for the existence of this modification. Although
such studies formed the basis for the belief that mam-
malian DNA is devoid of m6dA, they were done over
40 years ago and were hampered by low sensitivity (limit
of detection approximately 0.01 %) In contrast, more re-
cent studies have challenged the notion that eukaryotic
DNA does not contain m6dA. In 2006, Wion and col-
leagues used liquid chromatography coupled with mass
spectrometry to interrogate the mouse genome for the
presence of m6dA and detected very low levels of m6dA
(fewer than 1 m6dA per 106 nucleotides) [5]. Although
highly sensitive, such approaches can also lead to arti-
facts since trace amounts of bacterial contamination in
genomic preparations can result in the detection ofarticle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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Indeed, bacterial contamination is commonplace in mam-
malian culture systems, and bacteria are either commensal
organisms, or part of the diet of lower organisms such as
Caenorhabditis elegans and Drosophila.
A major advance came with the development of m6dA
mapping techniques in invertebrate organisms. Three re-
cent studies used global m6dA profiling methods to iden-
tify m6dA in the genomes of Chlamydomonas reinhardtii,
Drosophila melanogaster, and C. elegans, with levels of
m6dA ranging from 0.4 % to 0.001 % of total adenine resi-
dues within these genomes [6–8]. Since these methods
identified m6dA within a genomic sequence, the m6dA
could be definitively assigned to the invertebrate genome
rather than caused by bacterial contamination. These
studies have been an important advance in our under-
standing of the repertoire of epigenetic modifications in
higher organisms.
The outstanding question was whether m6dA is found
in higher organisms, including humans. A recent study
from Gurdon and colleagues [9] provides the first analysis
of vertebrate m6dA residues genome-wide. The study,
published in Nature Structural & Molecular Biology, ex-
amined the genomes of frogs, mice, and human cells using
ultra-high-performance liquid chromatography with tan-
dem mass spectrometry and revealed low levels of m6dA
in all three genomes (approximately 1 m6dA for every
1.2 × 106 deoxyadenosine residues, or 0.00009 % of deox-
yadenosine residues).
The authors then went on to globally profile m6dA
distribution within Xenopus and mouse genomes using
an m6dA antibody-based DNA immunoprecipitation
(DIP) method. In brief, this method involves immuno-
precipitating DNA fragments that contain m6dA using a
m6dA-specific antibody. Their analysis revealed a large
number of reads that cluster to form m6dA peaks in
these genomes (approximately 20,000–50,000 depending
on the tissue). Notably, only a small number of m6dA
peaks were located within genes (approximately 7–21 %).
Peaks within genes were largely excluded from exons, but
a higher number were located within intronic regions. In
addition, the authors observed a relative paucity of m6dA
sites immediately after transcription start sites (TSSs),
which contrasts with the marked enrichment of m6dA
within this region in C. elegans [8].
The authors validated their results by repeating the
global mapping studies in Xenopus using two additional
m6dA antibodies. There was a high degree of overlap of
individual m6dA peaks as well as overall m6dA distribu-
tion among all three antibodies tested, indicating that
the DIP-seq mapping technique is likely detecting valid
m6dA sites. When comparing m6dA sites across differ-
ent Xenopus tissues, there were subsets of m6dA sites
that were common to two or more tissues, but othersthat were unique. This may indicate tissue-specific
m6dA patterns, but warrants further investigation to
rule out sample-to-sample variability. Similarly, com-
parison of m6dA peaks in frog and mouse genomes re-
vealed some peaks that overlapped and others that were
distinct, which may be due to different tissues examined
in each species (testes, fat, and oviduct in frog and kid-
ney in mouse) or to species-specific methylation pat-
terns. Additional detailed analyses of m6dA distribution
across various tissues and in diverse species will likely
lend further insights into the tissue-/cell type-specific
distribution of m6dA as well as the consistency of m6dA
sites across species.
The overall pattern of m6dA localization observed in
the Gurdon study, as well as in the other recent m6dA
profiling studies, provides the first insights into the po-
tential function of m6dA. Although Gurdon and col-
leagues observe a slight enrichment of m6dA peaks just
upstream of TSSs, the most defining feature of m6dA
observed in this region is an absence of m6dA just after
the TSS. In contrast, Greer et al. report no clear distri-
bution of m6dA near genes in C. elegans [8], whereas
m6dA is enriched at and just after TSSs in Ch. reinhard-
tii [6]. These distinct distribution patterns might indicate
different roles for m6dA in vertebrates than in lower or-
ganisms. The fact that m6dA exhibits variable localization
around TSSs further suggests potential functions for this
modification in transcriptional regulation. Indeed, m6dA
in Ch. reinhardtii is associated with actively transcribed
genes [6]. However, further studies will be necessary to de-
termine whether m6dA is repressive or permissive for
transcription in vertebrates. Such analyses will also be use-
ful for understanding how relevant functional studies in
lower organisms are likely to be for understanding m6dA
in vertebrates.
Moving forward: m6dA regulatory pathways and
functional insights
A major priority right now for m6dA research is to un-
cover the function of m6dA, a task which will be facili-
tated by a more detailed understanding of the readers
and writers of this mark. A putative m6dA methyltrans-
ferase, DAMT-1, has been identified in C. elegans [8], al-
though the closest vertebrate homolog of this protein
(METTL4) has not yet been explored for m6dA-forming
potential. Notably, Gurdon and colleagues identify an
AG-rich motif which was enriched in m6dA peaks in
Xenopus. Two AG-containing motifs were also detected
at m6dA sites in C. elegans [8], suggesting that the m6dA
methyltransferase machinery in these organisms might
share a similar recognition sequence. However, efforts to
identify m6dA motifs in other higher eukaryotes, such as
mice and flies, have failed to identify consistent consen-
sus sequences [7, 9], suggesting the existence of other
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How does m6dA regulate DNA function? One possi-
bility is that m6dA mediates the recruitment of tran-
scription factors and/or m6dA binding proteins (Fig. 1).
Although readers of m6A in RNA have been identified,
proteins that specifically recognize methylated adenosine
residues in DNA remain to be uncovered. The major
epigenetic mark in vertebrates, m5C, is known to act in
part by recruiting m5C-binding proteins such as MECP2
[10], and it is possible that m6dA functions in an analo-
gous manner. Thus, a better understanding of the proteins
that read and write the m6dA mark will be necessary to
perform knockout studies that are likely to reveal m6dA
function.
Another possibility is that m6dA functions to destabilize
DNA duplexes. Although m6dA forms standard Watson:
Crick base pairs with thymidine, the base pairs between
m6dA and thymidine are less stable than canonical adeno-
sine:thymidine base pairs. Thus, m6dA may facilitate DNA
unwinding or the open state of DNA needed for transcrip-
tion initiation and other processes (Fig. 1).
An intriguing feature of m6dA across diverse organ-
isms is that its abundance is markedly decreased in more
evolved organisms. Could this be due to the evolution ofFig. 1 Methylated deoxyadenosine (m6dA) residues in DNA have the
potential for multiple functions within the eukaryotic genome. m6dA
residues might recruit m6dA-binding proteins (left), or m6dA might
prevent the binding of transcription factors (middle). In addition,
because N6 methylation of adenosines can influence Watson:Crick
base pairing, m6dA might act by inducing local DNA denaturation
(right). Any or all of these possible functional roles for m6dA have
the potential to influence transcription or other modes of gene
expression. Whether m6dA acts primarily by repressing or promoting
gene expression remains to be determinedactive m6dA demethylation pathways? In other words,
m6dA could occur frequently, but its rapid removal may
account for its low overall abundance in the genome.
NMAD-1, a homolog of the m6A RNA demethylase
ALKBH5, has shown evidence of m6dA demethylation
in C. elegans [8]. Interestingly, the Drosophila homolog
of Tet (called Dmad), which normally functions as a m5C
demethylase in vertebrates [11], was identified as a m6dA
demethylase in flies [7]. Its potential as a m6dA demethy-
lase in vertebrates, however, remains to be tested.
In addition to uncovering m6dA demethylases in verte-
brates, it will be important to determine whether these en-
zymes produce demethylated intermediates, as is seen with
the Tet-catalyzed production of 5-hydroxymethylcytidine
(hm5C) from m5C residues in eukaryotic DNA [11]. Thus,
there remains the possibility that the repertoire of modified
nucleotides expands beyond m6dA. Such intermediate
forms of modified adenine, if present, might also perform
unique functions in regulating gene expression and thus
represent important areas of future exploration.
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